(Q48665626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

main subject

phase I clinical trial

0 references

author

Paul Maruff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Peter J. Snyder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alexander Collie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Miss Amanda Darekar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

John P Huggins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

published in

Human Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

481-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia

21 January 2018

1 reference

Neuropsychological test performance in healthy volunteers before and after donepezil administration

21 January 2018

1 reference

7 January 2021

Practice effects and the use of alternate forms in serial neuropsychological testing

1 reference

7 January 2021

Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study

1 reference

7 January 2021

The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals.

1 reference

7 January 2021

1 reference

7 January 2021

A randomised, controlled trial of cognitive and psychomotor recovery from midazolam sedation following reversal with oral flumazenil.

1 reference

7 January 2021

A phase I study of AIT-082 in healthy elderly volunteers

1 reference

7 January 2021

What do subjective cognitive complaints in persons with aging-associated cognitive decline reflect?

1 reference

7 January 2021

Cognitive function as a predictor of survival in patients with recurrent malignant glioma.

1 reference

7 January 2021

Development of a statistical approach to classifying treatment response in individual children with ADHD.

1 reference

7 January 2021

Midazolam: a review of therapeutic uses and toxicity

1 reference

7 January 2021

The assessment of postoperative cognitive function

1 reference

7 January 2021

Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics

1 reference

7 January 2021

A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam

1 reference

7 January 2021

Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952205%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference